High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma
Leilei Zhou, Niek van Bree, Lola Boutin, Jinhye Ryu, Simon Moussaud, Mingzhi Liu, Magdalena Otrocka, Magnus Olsson, Anna Falk, Margareta Wilhelm
bioRxiv · Jan 31, 2024Cancer Biology